CHLORPHENIRAMINE MALEATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for chlorpheniramine maleate and what is the scope of patent protection?
Chlorpheniramine maleate
is the generic ingredient in twenty-three branded drugs marketed by Aurolife Pharma Llc, Glaxosmithkline, Schering Plough, Bel Mar, Elkins Sinn, Watson Labs, Schering, Pharm Assoc, Bayer Healthcare Llc, Avanthi Inc, Alza, Bayer Pharms, Anabolic, Bell Pharma, Impax Labs, Ivax Sub Teva Pharms, Kv Pharm, Lederle, Newtron Pharms, Panray, Pharmavite, Pharmeral, Pioneer Pharms, Purepac Pharm, Pvt Form, Roxane, Sun Pharm Industries, Vitarine, West Ward, Halsey, Lannett, Mainpointe, Acella, Tris Pharma Inc, Persion, Apozeal Pharms, Mayne Pharma Inc, Padagis Us, Haleon Us Holdings, Graham Dm, Novartis, Schwarz Pharma, Fisons, and Cent Pharms, and is included in sixty-two NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are twenty-one drug master file entries for chlorpheniramine maleate. Two suppliers are listed for this compound.
Summary for CHLORPHENIRAMINE MALEATE
US Patents: | 4 |
Tradenames: | 23 |
Applicants: | 44 |
NDAs: | 62 |
Drug Master File Entries: | 21 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Clinical Trials: | 9 |
Patent Applications: | 6,711 |
Drug Prices: | Drug price trends for CHLORPHENIRAMINE MALEATE |
What excipients (inactive ingredients) are in CHLORPHENIRAMINE MALEATE? | CHLORPHENIRAMINE MALEATE excipients list |
DailyMed Link: | CHLORPHENIRAMINE MALEATE at DailyMed |
Recent Clinical Trials for CHLORPHENIRAMINE MALEATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Dr. Ferrer BioPharma | Phase 2/Phase 3 |
Hospital CEMESA Cortés, San Pedro Sula, Honduras | Phase 2/Phase 3 |
Marcos Sanchez-Gonzalez, MD, PhD | Phase 2/Phase 3 |
Pharmacology for CHLORPHENIRAMINE MALEATE
Drug Class | Histamine-1 Receptor Antagonist |
Mechanism of Action | Histamine H1 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for CHLORPHENIRAMINE MALEATE
Anatomical Therapeutic Chemical (ATC) Classes for CHLORPHENIRAMINE MALEATE
US Patents and Regulatory Information for CHLORPHENIRAMINE MALEATE
Expired US Patents for CHLORPHENIRAMINE MALEATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alza | EFIDAC 24 CHLORPHENIRAMINE MALEATE | chlorpheniramine maleate | TABLET, EXTENDED RELEASE;ORAL | 019746-002 | Nov 18, 1994 | ⤷ Sign Up | ⤷ Sign Up |
Alza | EFIDAC 24 CHLORPHENIRAMINE MALEATE | chlorpheniramine maleate | TABLET, EXTENDED RELEASE;ORAL | 019746-002 | Nov 18, 1994 | ⤷ Sign Up | ⤷ Sign Up |
Alza | EFIDAC 24 CHLORPHENIRAMINE MALEATE | chlorpheniramine maleate | TABLET, EXTENDED RELEASE;ORAL | 019746-002 | Nov 18, 1994 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.